Pawsible
1 known investors
Vancouver-based venture fund and studio investing in and co-building early-stage pet health and animal wellness startups.
Also known as Pawsible Ventures · Pawsible Ventures Fund I
Investors · 1
Company profile
researched Aug 2026Pawsible Ventures is a Vancouver, British Columbia-based early-stage venture capital firm and venture studio focused on pet health, animal wellness and animal technology. Announced on 9 October 2025, its inaugural vehicle is a $10 million USD fund (reported by one trade outlet as CAD 10 million) earmarked for pre-seed and incubation-stage companies addressing what the firm describes as a $250 billion-plus global pet health and wellness market. The firm combines capital, incubation and distribution in a single platform, running quarterly studio cohorts in which entrepreneurs and veterinarians co-create and validate new products.
The fund deploys both internally, into companies created inside the studio, and externally into strategic opportunities, with initial checks of $100,000 to $500,000 and capacity for follow-on investment. Over three years Pawsible targets 15 to 20 startups under a global mandate, with stated emphasis on backing Canadian founders and helping them scale internationally, particularly into the United States. Its first cohort focuses on veterinary care and practice management, diagnostics, biohealth and insurance, AI and automation tools for veterinarians, behavioural and emotional wellness, and personalized pharmaceuticals and wellness products. A directory listing describes an investment scope covering PetTech, biotechnology, health and wellness, consumer products and digital health across Canada and the United States at pre-seed and seed stages, with check sizes from $25,000 to $2 million.
Founding story
Pawsible Ventures was co-founded by Alex Chieng, who serves as Co-Founder and CEO, and Shafin Diamond Tejani, Co-Founder and CEO of Victory Square Technologies. Chieng previously co-founded Vetsie, described as one of North America's first veterinary telemedicine and AI platforms, is a graduate of the Founder Institute, a co-winner of what the announcement calls the world's largest AI hackathon, and an alumnus of Leap Ventures, an accelerator backed by Mars Petcare. Tejani has nearly three decades of experience building technology companies across healthtech, AI, gaming, climate tech and Web3, and through Victory Square has built a portfolio of more than 40 startups in over 20 countries, including Hydreight Technologies. The two founders positioned Pawsible to address what they characterize as a shortage of capital and operational support for early-stage animal health founders.
Business model
Pawsible operates a combined fund-and-studio model: it invests capital at pre-seed and incubation stage, incubates companies internally through quarterly cohorts, and provides distribution access. Portfolio companies plug into Victory Square's healthcare infrastructure, described as more than 3,000 nurses and doctors across North America, a national pharmacy network with compounding capability, clinics and direct-to-consumer telehealth channels, and integrated lab systems for diagnostics and preventative care. Capital is deployed both into studio-created ventures and into external companies.
Traction
At launch the firm reported a $10 million inaugural fund with cornerstone investors including technology operators, health innovators and publicly traded venture builder Victory Square Technologies, with clinic network Hydreight Technologies also cited as backing the fund. Applications for the first incubator cohort were open as of October 2025, with the cohort slated to launch later that year. The firm targets 15 to 20 investments over three years.
Latest developments
In December 2025, pet industry trade press reported Pawsible Ventures among a group of pet tech and pet food companies raising capital, describing the October 2025 launch of its CAD 10 million ($7 million) fund and studio backed by Victory Square Technologies and its plan to back 15 to 20 startups globally over three years.
▸Full profile — market position, go-to-market, geography, history
Market position
Pawsible presents itself as a specialist early-stage platform in animal health rather than a generalist fund, differentiating on the combination of capital, in-house company building and distribution through an affiliated human-health network. Trade coverage grouped its launch alongside a broader wave of 2025 pet tech and pet food financings, noting it as a dedicated venture fund entering the sector.
The firm's stated differentiator is bundling capital, incubation and ready-made distribution in one platform, giving portfolio companies immediate access to Victory Square's existing clinical, pharmacy, telehealth and laboratory channels rather than requiring them to build commercial infrastructure from scratch. Its studio model pairs entrepreneurs with veterinarians to co-create and validate products in quarterly cohorts.
Go-to-market
The firm sources companies through open applications to its incubator cohorts, announced as open at the time of its October 2025 launch, and raises from accredited investors who are directed to request participation details directly. Media outreach was conducted via a paid newswire release distributed through ACCESS Newswire and carried by financial and trade publications, alongside coverage in Canadian startup press.
Founders and early-stage startups in pet and animal health, including companies working on veterinary care and practice management software, diagnostics, biohealth, pet insurance, AI and automation tools for veterinarians, behavioural and emotional wellness, and personalized pharmaceuticals and wellness products. On the capital side, the firm solicits participation from accredited investors.
Geography
Headquartered in Vancouver, Canada. The investment mandate is global, with a stated emphasis on Canadian founders scaling into the United States; a directory listing identifies Canada and the United States as countries of investment.
History
Pawsible Ventures publicly launched its $10 million fund and venture studio on 9 October 2025 via a newswire announcement from Vancouver. As of a February 2026 directory update the firm was listed as active, investing at pre-seed and seed stages across PetTech, biotechnology, health and wellness, consumer products and digital health.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 2
launches, deals, and filingsPawsible Ventures announced the launch of a $10 million venture fund and studio for pre-seed and incubation-stage pet health and animal wellness companies, with cornerstone investors including technology operators, health innovators and publicly traded venture builder Victory Square Technologies; BetaKit also cited clinic network Hydreight Technologies as backing the fund. One trade report described the vehicle as CAD 10 million (approximately $7 million).
$10M source ↗
Applications opened for Pawsible's first incubator cohort, planned to launch later in 2025, focused on veterinary care and practice management, diagnostics, biohealth and insurance, AI and automation tools for veterinarians, behavioural and emotional wellness, and personalized pharmaceuticals and wellness products.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 7
primary sources listed
- Pawsible Venturesventurecapitalarchive.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Pawsible do?
- Vancouver-based venture fund and studio investing in and co-building early-stage pet health and animal wellness startups.
- Who are Pawsible's investors?
- Pawsible's investors include Victory Square Technologies.